Hepatitis C virus resistance to protease inhibitors
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference87 articles.
1. Expert opinion on the treatment of patients with chronic hepatitis C;Zeuzem;J Viral Hepat,2009
2. HCV drug discovery aimed at viral eradication;Schinazi;J Viral Hepat,2010
3. New therapies for hepatitis C virus infection;Soriano;Clin Infect Dis,2009
4. Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C;Forestier;Hepatology,2007
5. Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients;Lawitz;J Hepatol,2008
Cited by 278 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09
2. The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19;Pharmaceutics;2024-02-02
3. Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir;Nature;2023-09-11
4. Structure-based virtual screening of natural compounds against wild and mutant (R1155K, A1156T and D1168A) NS3-4A protease of Hepatitis C virus;Journal of Biomolecular Structure and Dynamics;2023-08-30
5. Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development;Scientific Reports;2023-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3